|
Paragon Ventures is a leading strategic advisory for healthcare business owners considering a potential sale, merger, or recapitalization of their business.
If you are interested in SELLING your business, the current M&A markets include many well-qualified buyers, strong valuations and options for management. Contact us today to confidentially explore your strategic options.
|
|
|
|
|
|
|
Diversity Of Buyers & Investors
|
Strategic Integration Synergies
|
|
|
|
Abundant Acquisition Capital
|
Growth & Management Options
|
|
|
|
|
|
|
If you are interested in ACQUIRING a business, below are some select opportunities currently available. Please call or email us to request a comprehensive information memorandum on available acquisition opportunities. To request an NDA, for specific acquisition opportunities: click here.
|
|
|
|
|
|
|
Acquisition Opportunity #NE218-70050
Retail Pharmacy:
Urban Location with 340B Contracts
Available for acquisition is retail pharmacy with 340B contracts. The pharmacy dispenses medications in a densely populated and growing community. Utilizing advanced technologies, the pharmacy can efficiently dispense a greater volume of medications. The business is strategically located in a major metropolitan area and enjoys access to prime contractual relationships including multiple 340B network contracts. In 2017, the business generated revenue of $15MM. 2018 dispensing activity is trending a 15% increase over prior year as new contracts are implemented. For the YTD July 2018, annualized revenues now exceed $16.5MM and generating EBITDA in excess of $2.1MM. With the continued expansion of new contracts, the pharmacy is well positioned for extraordinary growth.
|
|
|
|
|
|
|
Acquisition Opportunity #NE218-70050
Specialty Pharmacy:
A Strategic Metropolitan Opportunity
Available for acquisition is a multi-accredited specialty pharmacy focused on providing advanced medications to a growing patient population. The Company is strategically located in a major northeastern metropolitan area and currently licensed in seven US States. The Company is led by an exemplary team managing compliant operations while driving growth in revenue and profitability. The business enjoys access to prime contractual payor relationships and referral sources. The management team developed and has deployed advanced dispensing, information management and customer service technologies which are in place to scale the business. For the trailing twelve month period ending June 2018, the Company generated $75MM in revenues with EBITDA exceeding $4.3MM.
|
|
|
|
|
|
|
Acquisition Opportunity #NE317-98025
Retail & Specialty Pharmacy:
HIV, Transplant, Fertility, and HepC
Well established, dual-accredited pharmacy operating out of four prime metropolitan locations. The pharmacies provide specialty and retail medications along with related medical supplies. The pharmacies are currently licensed in 21 States and continue to identify expansion opportunities in new markets nationally. The company works closely with physicians, patient care providers and insurance companies to achieve the highest quality of care and customer service. This company offers medications for the treatment of Hepatitis-C, Fertility, Transplant, HIV, Hemophilia and other specialty therapies. For the trailing twelve-month period ending June 2018, the business had gross revenues of $77.95MM. The company generated adjusted EBITDA of over $5.01MM. The pharmacy is well positioned for continued growth with solid contracts and referral relationships.
|
|
|
|
|
|
|
Acquisition Opportunity #NE218-03030
Wholesale Distributor:
Pharmaceuticals & Medical Supplies
Available for acquisition is a well-established and rapidly growing distributor of medical products and wholesaler of pharmaceuticals. The Company is a growing provider of products to customers in free standing healthcare facilities, addiction treatment centers, surgical centers, institutional health services departments, physician offices, senior care facilities, homecare providers, and other similar markets. The Company has over 10 years of experience in providing the goods and services to its customers and has a strong and growing referral base. For the year ending 2017, the company generated revenue of $3.9MM with $665K in adjusted EBITDA. For the year end 2018, the company is expected to generate over $4.3MM revenues with adjusted EBITDA exceeding $730K.
|
|
|
|
|
|
|
Paragon Ventures tracks and provides insight into strategic merger and acquisition activity of privately held and corporate buyers and investors. Our Healthcare Market Pulse® reports select M&A transactions across the continuum of healthcare. Click here to view our Healthcare Market Pulse® on our website.
|
|
|
|
|
|
|
Paragon Ventures is a leading strategic advisory for healthcare business owners considering a potential sale, merger, or recapitalization of their business. All inquiries are held strictly confidential.
|
|
|
|
|
Follow RXinsider on Social Media
|
|
|
|
|
